TOP TIERMARKET NEWSWIRE
SEC Form 4 history

LIGAND PHARMACEUTICA (LGND) insider trades

LIGAND PHARMACEUTICA (LGND) insider trading activity (SEC Form 4). Over the trailing 90 days, LGND insiders filed 0 purchases totalling $0 and 6 sales totalling $16.1M — net SELLING of $16.1M. Most recent filing: Sep 14, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
6
$16.1M
Net (90d)
-$16.1M
net selling
Most recent
Sep 14, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Sep 14, 2026Zimmermann MartineDirS Sale—$285.00$342Kfiling
Sep 8, 2026Reardon AndrewCLO, SecretaryS Sale—$286.09$1.4Mfiling
Aug 14, 2026Haas JasonDirS SaleOE—$292.81$2.1Mfiling
Aug 14, 2026Espinoza OctavioCFOS SaleOE—$292.07$9.2Mfiling
Aug 4, 2026Reardon AndrewCLO, SecretaryS SaleOE—$288.99$1.4Mfiling
Jul 6, 2026Reardon AndrewCLO, SecretaryS SaleOE—$313.28$1.6Mfiling
Jun 18, 2026Sabba Stephen LDirS SaleOE—$254.00$545Kfiling
Jun 15, 2026Haas JasonDirS SaleOE—$255.58$1.7Mfiling
Jun 12, 2026Aryeh JasonDirS SaleOE—$250.00$1.3Mfiling
Jun 12, 2026Lamattina John LDirS Sale—$250.88$1.2Mfiling
Jun 2, 2026Reardon AndrewCLO, SecretaryS SaleOE—$227.06$1.1Mfiling
May 14, 2026Kozarich John WDirS SaleOE—$225.14$563Kfiling